The expression of YAP1 is increased in high-grade prostatic adenocarcinoma but is reduced in neuroendocrine prostate cancer
Siyuan Cheng, Néstor Prieto‐Domínguez, Shu Yang, Zachary M. Connelly, Samantha StPierre, Bryce Rushing, Andy Watkins, Lawrence Shi, Meredith A. Lakey, Lyndsey Buckner Baiamonte, Tajammul Fazili, A. Lurie, Eva Corey, Runhua Shi, Yunshin Yeh, Xiuping Yu
Topics & Concepts
YAP1Prostate cancerMedicineProstateImmunohistochemistryCancer researchNeuroendocrine differentiationAdenocarcinomaCancerInternal medicinePathologyOncologyBiologyTranscription factorGeneBiochemistryHippo pathway signaling and YAP/TAZProstate Cancer Treatment and ResearchProstate Cancer Diagnosis and Treatment